RENAISSANCE TECHNOLOGIES LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1037389 NEW YORK, NY

Back to SUPN Full portfolio

Position in SUPN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$88,142,925

+$2,036,582 QoQ

Shares Held

1,705,222

-1.6% QoQ

Ownership

2.94%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,196,847,717 across 49 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	1,787,019	$1,059,666,526
2	NBIX	Neurocrine Biosciences Inc	2,418,897	$318,665,490
3	ALKS	Alkermes plc.	6,160,428	$217,832,734
4	RDY	Dr Reddys Laboratories Ltd	7,859,728	$108,857,232
5	SUPN	Supernus Pharmaceuticals, Inc. This page	1,705,222	$88,142,925
6	TAK	Takeda Pharmaceutical Co Ltd	2,989,100	$55,358,132
7	COLL	Collegium Pharmaceutical, Inc	1,469,449	$48,594,678
8	HIMS	Hims & Hers Health, Inc.	2,118,080	$43,971,340

All Filings in SUPN

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$88,142,925	1,705,222	-1.6%	Shares	Sole	2026-05-14
2025-12-31	$86,106,343	1,732,522	-0.5%	Shares	Sole	2026-02-12
2025-09-30	$83,184,325	1,740,622	+5.2%	Shares	Sole	2025-11-13
2025-06-30	$52,175,749	1,655,322	+4.4%	Shares	Sole	2025-08-13
2025-03-31	$51,932,395	1,585,722	-0.8%	Shares	Sole	2025-05-14
2024-12-31	$57,809,787	1,598,722	-7.5%	Shares	Sole	2025-02-13
2024-09-30	$53,898,433	1,728,622	+2.6%	Shares	Sole	2024-11-13
2024-06-30	$45,077,013	1,685,122	+26.4%	Shares	Sole	2024-08-09
2024-03-31	$45,476,202	1,333,222	-3.3%	Shares	Sole	2024-05-13
2023-12-31	$39,891,532	1,378,422	-4.2%	Shares	Sole	2024-02-13
2023-09-30	$39,657,294	1,438,422	-3.9%	Shares	Sole	2023-11-14
2023-06-30	$44,979,439	1,496,322	+7.4%	Shares	Sole	2023-08-11
2023-03-31	$50,487,302	1,393,522	+10.6%	Shares	Sole	2023-05-12
2022-12-31	$44,962,819	1,260,522	-1.5%	Shares	Sole	2023-02-13
2022-09-30	$43,335,514	1,280,222	-8.4%	Shares	Sole	2022-11-14
2022-06-30	$40,401,876	1,397,022	+12.3%	Shares	Sole	2022-08-12
2022-03-31	$40,190,631	1,243,522	+0.4%	Shares	Sole	2022-05-13
2021-12-31	$36,132,797	1,239,122	-10.8%	Shares	Sole	2022-02-11
2021-09-30	$37,034,548	1,388,622	-8.4%	Shares	Sole	2021-11-12
2021-06-30	$46,684,475	1,516,222	-13.9%	Shares	Sole	2021-08-13
2021-03-31	$46,082,611	1,760,222	-4.8%	Shares	Sole	2021-05-13
2020-12-31	$46,533,973	1,849,522	-1.0%	Shares	Sole	2021-02-10
2020-09-30	$38,939,540	1,868,500	+17.3%	Shares	Sole	2020-11-13
2020-06-30	$37,829,000	1,592,800	+76.5%	Shares	Sole	2020-08-13
2020-03-31	$16,230,578	902,200	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.